Lipocine Inc (NASDAQ: LPCN) stock enjoyed a major increase of 12.8% on 4/10/24. The shares closed at $6.51. Moreover, this advance was accompanied by exceptionally high trading volume at 212% of normal. The stock has risen 31.0% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, LPCN is expected to continue to be a modest Value Eraser.
Lipocine has a current Value Trend Rating of C (Low Neutral). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Lipocine has a neutral Appreciation Score of 51 and a neutral Power Rating of 45, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment